相似文献
1
Role of Sodium Channels in Epilepsy.
Cold Spring Harb Perspect Med. 2016 Jun 1;6(6):a022814. doi: 10.1101/cshperspect.a022814.
2
BmK AEP, an Anti-Epileptic Peptide Distinctly Affects the Gating of Brain Subtypes of Voltage-Gated Sodium Channels.
Int J Mol Sci. 2019 Feb 8;20(3):729. doi: 10.3390/ijms20030729.
3
Cholesterol metabolite cholestane-3β,5α,6β-triol suppresses epileptic seizures by negative modulation of voltage-gated sodium channels.
Steroids. 2015 Jun;98:166-72. doi: 10.1016/j.steroids.2014.12.025. Epub 2015 Jan 8.
4
Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
Channels (Austin). 2013 May-Jun;7(3):146-52. doi: 10.4161/chan.24380. Epub 2013 Mar 26.
5
Introduction to sodium channels.
Handb Exp Pharmacol. 2014;221:1-6. doi: 10.1007/978-3-642-41588-3_1.
6
Voltage-gated sodium channels in epilepsy.
Epilepsia. 2002 Nov;43(11):1278-95. doi: 10.1046/j.1528-1157.2002.40501.x.
7
Voltage-gated Sodium Channels in Sensory Information Processing.
CNS Neurol Disord Drug Targets. 2019;18(4):273-278. doi: 10.2174/1871527317666180627114849.
8
Understanding Genotypes and Phenotypes of the Mutations in Voltage- Gated Sodium Channel α Subunits in Epilepsy.
CNS Neurol Disord Drug Targets. 2019;18(4):266-272. doi: 10.2174/1871527317666181026164825.
9
Distribution and function of voltage-gated sodium channels in the nervous system.
Channels (Austin). 2017 Nov 2;11(6):534-554. doi: 10.1080/19336950.2017.1380758. Epub 2017 Nov 8.
10
Mechanisms of action of currently used antiseizure drugs.
Neuropharmacology. 2020 May 15;168:107966. doi: 10.1016/j.neuropharm.2020.107966. Epub 2020 Jan 14.
引用本文的文献
1
Unraveling the nutritional challenges in epilepsy: Risks, deficiencies, and management strategies: A systematic review.
World J Exp Med. 2025 Jun 20;15(2):104328. doi: 10.5493/wjem.v15.i2.104328.
2
Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.
Epilepsy Behav. 2025 Jul;168:110421. doi: 10.1016/j.yebeh.2025.110421. Epub 2025 Apr 17.
3
Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy.
Acta Epileptol. 2023 Jun 28;5(1):16. doi: 10.1186/s42494-023-00127-2.
4
Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.
medRxiv. 2025 Jan 31:2025.01.02.25319900. doi: 10.1101/2025.01.02.25319900.
5
Deregulated ion channels contribute to RHOBTB2-associated developmental and epileptic encephalopathy.
Hum Mol Genet. 2025 Mar 20;34(7):639-650. doi: 10.1093/hmg/ddae183.
6
SCN1A Genetic Alterations and Oxidative Stress in Idiopathic Generalized Epilepsy Patients: A Causative Analysis in Refractory Cases.
Indian J Clin Biochem. 2025 Jan;40(1):105-110. doi: 10.1007/s12291-023-01164-x. Epub 2023 Nov 30.
7
The Oxidative Stress in Epilepsy-Focus on Melatonin.
Int J Mol Sci. 2024 Dec 2;25(23):12943. doi: 10.3390/ijms252312943.
8
Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.
ACS Chem Neurosci. 2024 Sep 4;15(17):3228-3256. doi: 10.1021/acschemneuro.4c00438. Epub 2024 Aug 21.
9
A Systematic Review of the Anti-seizure and Antiepileptic Effects and Mechanisms of Piperine.
Cent Nerv Syst Agents Med Chem. 2025;25(2):143-156. doi: 10.2174/0118715249297934240630111059.
10
Clinical features and genetic analysis of developmental and epileptic encephalopathy caused by biallelic variants of .
Heliyon. 2024 Jun 7;10(12):e32693. doi: 10.1016/j.heliyon.2024.e32693. eCollection 2024 Jun 30.
本文引用的文献
1
The phenotypic spectrum of SCN8A encephalopathy.
Neurology. 2015 Feb 3;84(5):480-9. doi: 10.1212/WNL.0000000000001211. Epub 2015 Jan 7.
2
'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour.
Hum Mol Genet. 2015 Mar 1;24(5):1457-68. doi: 10.1093/hmg/ddu562. Epub 2014 Nov 6.
3
Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
Epilepsy Res. 2014 Nov;108(9):1511-8. doi: 10.1016/j.eplepsyres.2014.08.020. Epub 2014 Sep 4.
4
Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.
Hum Mol Genet. 2015 Jan 15;24(2):506-15. doi: 10.1093/hmg/ddu470. Epub 2014 Sep 16.
5
A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
Neurobiol Dis. 2014 Sep;69:117-23. doi: 10.1016/j.nbd.2014.05.017. Epub 2014 May 27.
6
Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
J Neurophysiol. 2014 Aug 15;112(4):903-12. doi: 10.1152/jn.00135.2014. Epub 2014 May 7.
7
Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De Novo missense mutation in the SCN2A gene.
Neuropediatrics. 2014 Aug;45(4):261-4. doi: 10.1055/s-0034-1372302. Epub 2014 Apr 7.
8
Physiological and genetic analysis of multiple sodium channel variants in a model of genetic absence epilepsy.
Neurobiol Dis. 2014 Jul;67:180-90. doi: 10.1016/j.nbd.2014.03.007. Epub 2014 Mar 19.
9
Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy.
Epilepsia. 2014 Apr;55(4):601-8. doi: 10.1111/epi.12568. Epub 2014 Mar 7.
10
Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Epilepsia. 2014 Apr;55(4):e25-9. doi: 10.1111/epi.12554. Epub 2014 Mar 1.
Zotero 插件